Back to top
more

NanoString Technologies, Inc. (NSTG)

(Delayed Data from NSDQ)

$27.96 USD

27.96
266,767

+0.86 (3.17%)

Updated May 3, 2019 04:00 PM ET

After-Market: $27.94 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Better trading starts here.

Zacks News

Will NanoString Technologies Continue to Surge Higher?

As of late, it has definitely been a great time to be an investor in NanoString Technologies.

NanoString Technologies (NSTG) Reports Q3 Loss, Tops Revenue Estimates

NanoString (NSTG) delivered earnings and revenue surprises of -12.28% and 9.09%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate NanoString Technologies (NSTG) to Report a Decline in Earnings: What to Look Out for

NanoString (NSTG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

NanoString Technologies (NSTG) Reports Q2 Loss, Tops Revenue Estimates

NanoString (NSTG) delivered earnings and revenue surprises of -3.64% and 4.64%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

Will NanoString Technologies (NSTG) Report Negative Earnings Next Week? What You Should Know

NanoString (NSTG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

NanoString Technologies (NSTG) Reports Q1 Loss, Tops Revenue Estimates

NanoString (NSTG) delivered earnings and revenue surprises of -6.15% and 8.91%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

Can Core Business Unit Fuel McKesson (MCK) Q4 Earnings?

Anticipated growth across core business unit and solid show by Medical Surgical and European Pharmaceutical Solutions is likely to aid McKesson's (MCK) Q4 earnings. However, rising costs might be a dampener.

What's in Store for Cardinal Health (CAH) in Q3 Earnings?

Better-than-expected performance at Pharmaceutical and Medical segments and diverse product portfolio is likely to aid Cardinal Health (CAH) in Q3 earnings. However, stiff competition might play spoilsport.

NanoString Technologies (NSTG) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

NanoString (NSTG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

What's in the Cards for DaVita (DVA) This Earnings Season?

Better-than-expected performance at Kidney Care, strategic buyouts and international expansion might aid DaVita (DVA) in Q1. However, integration risks might be a dampener.

Can Dental Growth Drive Henry Schein's (HSIC) Q1 Earnings?

Henry Schein (HSIC) is consistently riding on segmental strength at Dental, Medical and Technology plus Value-Added Services.

Can Steady CAG Growth Drive IDEXX's (IDXX) Q1 Earnings?

Idexx (IDXX) is expected to continue reporting solid revenue growth on robust CAG performance.

Can Breast Health Growth Drive Hologic's (HOLX) Q2 Earnings?

Hologic's (HOLX) Breast Health segment is witnessing a rapid uptick on the back of large installed base of market-leading, clinically differentiated Genius 3D mammography systems.

Will Pharmacy Services Drive CVS Health's (CVS) Q1 Earnings?

Within Pharmacy Services, despite a fierce pricing competition, CVS Health (CVS) is currently riding on high level of service and execution, competitive pricing and a unique integrated model.

Will Pricing Pressure Hurt Zimmer Biomet (ZBH) Q1 Earnings?

With Zimmer Biomet (ZBH) focusing solely on this restructuring initiative, chances are slim for the company to post promising growth performances across its operating segments.

Can Covance Business Growth Aid LabCorp (LH) in Q1 Earnings?

Within Covance Drug Development, LabCorp (LH) is expected to drive profitable growth through expanded solutions and enhanced operational capabilities.

Can iTotal PS Revenues Drive ConforMIS' (CFMS) Q1 Earnings?

ConforMIS (CFMS) expects to register solid revenue growth on robust performance by its product lines as well as steady royalties.

Can Front Line Care Drive Hill-Rom's (HRC) Q2 Earnings?

Hill-Rom (HRC) consistently reports strong Core revenue growth in domestic and international markets on solid segmental performance.

Can Core Renal Care Unit Drive Baxter's (BAX) Q1 Earnings?

Strong performance across Renal Care, Clinical Nutrition, Advanced Surgery and Acute Therapies businesses might aid Baxter (BAX) in Q1. However, lower sales at Pharmaceutical business might be a woe.

Urmimala Biswas headshot

3 Medical Product Stocks Set to Beat This Earnings Season

The global medical device space takes significant strides in terms of research and development (R&D) and regulatory progress in the first quarter.

Can Core MedSurg Segment Drive Stryker's (SYK) Q1 Earnings?

Solid segmental performances at Medsurg, Orthopaedic and Neurotechnology & Spine along with an upbeat 2019 view are likely to support Stryker (SYK) in Q1. But integration risks might be a dampener.

Will Diagnostics Business Ail LabCorp (LH) in Q4 Earnings?

LabCorp (LH) is likely to gain traction from the company's collaboration with Walgreens.

Zacks.com featured expert Kevin Matras highlights: Meet, Zai Lab, NanoString Technologies, OSI Systems and AudioEye

Zacks.com featured expert Kevin Matras highlights: Meet, Zai Lab, NanoString Technologies, OSI Systems and AudioEye

Can Boston Scientific (BSX) Q4 Earnings Fuel Overall Growth?

We are hopeful that Boston Scientific (BSX) will report a strong IC business globally in Q4, backed by an innovative portfolio and robust commercial teams.

5 Stocks With Recent Price Strength to Enhance Your Return

Investors target stocks that have been on a bullish run lately. Actually, stocks seeing price strength have a high chance of carrying the momentum forward.